Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 31Active not recruiting 14Completed 7Not yet recruiting 5Terminated 4Enrolling by invitation 2Withdrawn 1Suspended 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Dermatologic 2

Conditions

Neoplasms 31Prostatic Neoplasms 13Breast Neoplasms 13Colorectal Neoplasms 12Hematologic Neoplasms 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Lung Neoplasms 6Stomach Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Uterine Cervical Neoplasms 4Pancreatic Neoplasms 4Myasthenia Gravis 4Melanoma 4Lymphoma, Non-Hodgkin 4Leukemia, Myeloid, Acute 4Head and Neck Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Adenocarcinoma 4Pain 3Ovarian Neoplasms 3Leukemia, Lymphocytic, Chronic, B-Cell 3Leukemia 3Hematopoietic and Lymphatic System Neoplasm 3Hematologic Diseases 3Glioma 3Gastrointestinal Neoplasms 3Carcinoma, Renal Cell 3Brain Neoplasms 3Anxiety Disorders 3Urinary Bladder Neoplasms 2

Interventions

oxycodone-acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Enrolling by invitation × Skin Neoplasms × 90 days × Clear all
NCT07575230 2026-05-11

Suzetrigine vs Norco-postoperative Mohs Pain

Baylor Research Institute

Phase 4 Enrolling by invitation
75 enrolled
Dermatologic

Skin Neoplasms

NCT03503240 2026-05-06

Patient Satisfaction With Appearance, Scar Outcome and Quality of Life After Skin Cancer Surgery

Memorial Sloan Kettering Cancer Center

Enrolling by invitation
3,000 enrolled
Dermatologic

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡